Skiles, J.W. et al, Biorg. Med. Chem. Lett. 1993, 3(4), pp. 773-778. |
R. Freidinger, et al., "Protected Lactam-Bridged Dipeptides for Use as Conformational Constraints in Peptides," J. Org. Chem., 47:104-109, 1982. |
H. Vieweg, et al., "Synthese von N-alpha-(arylsulphonylglycyl)-3-amidinophenulalaninest ern als aktive and relativ spezfische Inhibtoren von Faktor Xa," Pharmazie, vol. 42, No. 4, Apr. 1987, Berlin DD p. 268. |
G. Wagner, et al., "Synthese von N-alpha-(Tosyl-beta-alanyl)-und N-alpha-(Tosyl-espsilon-aminocapronyl) amidinophenylalanylamiden als stark wirksame thrombininhititoren,"Pharmazie, vol. 39, No. 5, May 1984, Berlin DD pp. 315-317. |
D. Carini, et al., "Nonpeptide Angiotensin II Receptor Antagoists:The Discovery of a Series of V-(Biphenylylmethyl) imidazoles as Potent, Orally Active Antihypertensives," J. Med. Chem., vol. 34, No. 8, pp. 2525-2547, 1991. |